Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | BCL6 | P41182 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15510403 | 0.83 | MAPT (0.74) | MAPTPKMKDM4ELMNAALDH1A1 | |
| SCHEMBL29972743 | 0.80 | ALDH1A1 (0.57) | ATG4BMAPTPKMNPC1RAB9A | |
| SCHEMBL223763 | 0.80 | ATG4B (0.56) | ATG4BMAPTPKMNPC1RAB9A | |
| SCHEMBL805874 | 0.80 | LMNA (0.57) | ATG4BMAPTPKMNPC1RAB9A | |
| SCHEMBL569878 | 0.80 | RAB9A (0.65) | MAPTPKMNPC1RAB9AKDM4E | |
| SCHEMBL525722 | 0.80 | ALDH1A1 (0.57) | ATG4BMAPTPKMNPC1RAB9A | |
| SCHEMBL11186307 | 0.78 | PKM (0.69) | MAPTPKMNPC1RAB9AKDM4E | |
| SCHEMBL23220314 | 0.77 | MAPT (0.61) | MAPTPKMKDM4EALDH1A1KMT2A | |
| SCHEMBL9383012 | 0.77 | PKM (0.56) | ATG4BMAPTPKMNPC1RAB9A | |
| SCHEMBL14031230 | 0.77 | MAPT (0.61) | MAPTPKMKDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7494815-B2 | Method and apparatus for analyzing compounds with amino group | AJINOMOTO CO., INC. (JP) | 2009-02-24 | — | — | US | claimed |
| US-20070269899-A1 | METHOD AND APPARATUS FOR ANALYZING COMPOUNDS WITH AMINO GROUP | AJINOMOTO CO. INC. (JP) | 2007-11-22 | — | — | US | claimed |
| EP-1750126-A1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | Ajinomoto Co., Inc. (JP) | 2007-02-07 | — | — | EP | claimed |
| US-20110071141-A1 | Pesticidial Condensed-Ring Aryl Compounds | BAYER CROPSCIENCE AG | 2011-03-24 | — | — | US | disclosed |
| EP-2254863-A1 | PESTICIDAL CONDENSED - RING ARYL COMPOUNDS | Bayer CropScience AG (DE) | 2010-12-01 | — | — | EP | disclosed |
| US-20090233960-A1 | Kinase Inhibitors | DEVGEN NV (BE) | 2009-09-17 | — | — | US | disclosed |
| WO-2009112275-A1 | PESTICIDAL CONDENSED - RING ARYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-09-17 | — | — | WO | disclosed |
| US-7494815-B2 | Method and apparatus for analyzing compounds with amino group | AJINOMOTO CO., INC. (JP) | 2009-02-24 | — | — | US | disclosed |
| EP-1934181-A2 | KINASE INHIBITORS | Devgen NV (BE) | 2008-06-25 | — | — | EP | disclosed |
| US-20070269899-A1 | METHOD AND APPARATUS FOR ANALYZING COMPOUNDS WITH AMINO GROUP | AJINOMOTO CO. INC. (JP) | 2007-11-22 | — | — | US | disclosed |
| WO-2007042321-A2 | KINASE INHIBITORS | DEVGEN N.V. (BE) | 2007-04-19 | — | — | WO | disclosed |
| EP-1750126-A1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | Ajinomoto Co., Inc. (JP) | 2007-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071141-A1 | Pesticidial Condensed-Ring Aryl Compounds | DDT, PRDX4, CYP4X1 | ATG4B 940/4885MAPT 4341/4885PKM 566/4885 |
| US-20090233960-A1 | Kinase Inhibitors | ROCK1, MAP3K1, MAP3K11 | ATG4B 4564/4885MAPT 156/4885PKM 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.